Saturday, June 13, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,769
Drugs linked 4,797

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 182 of 1,261

  1. US 11701354

    Pyrazolo[3,4-b]pyrazine derivatives as SHP2 phosphatase inhibitors

    Relay Therapeutics, Inc. · Granted Jul 18, 2023 · Expires Jul 13, 2043

    granted

  2. US 11701427

    Diels-alder conjugation methods

    REGENERON PHARMACEUTICALS, INC. · Granted Jul 18, 2023 · Expires Jul 13, 2043

    granted

  3. US 11701361

    p110-delta inhibitors treat and prevent autoimmunity while sparing the ability to mount an immune response to exogenous immunogens

    The Regents of the University of Colorado · Granted Jul 18, 2023 · Expires Jul 13, 2043

    granted

  4. US 11701386

    Cell

    AUTOLUS LIMITED · Granted Jul 18, 2023 · Expires Jul 13, 2043

    granted

  5. US 11702480

    Engineered antibodies and uses thereof

    The Regents of the University of California · Granted Jul 18, 2023 · Expires Jul 13, 2043

    granted

  6. US 11702646

    Methods for modulating RNA splicing

    PTC THERAPEUTICS, INC. · Granted Jul 18, 2023 · Expires Jul 13, 2043

    granted

  7. US 11702389

    Piperidine derivatives as HDAC1/2 inhibitors

    Regenacy Pharmaceuticals, Inc. · Granted Jul 18, 2023 · Expires Jul 13, 2043

    granted

  8. US 11701355

    Levosimendan for treating pulmonary hypertension with heart failure with preserved ejection fraction (PH-HFpEF)

    TENAX THERAPEUTICS, INC. · Granted Jul 18, 2023 · Expires Jul 13, 2043

    granted

  9. US 11702427

    Substituted 2-pyridone tricyclic compounds, analogues thereof, and methods using same

    ARBUTUS BIOPHARMA CORPORATION · Granted Jul 18, 2023 · Expires Jul 13, 2043

    granted

  10. US 11701394

    Compositions and methods for treating cholestatic disease

    Seres Therapeutics, Inc. · Granted Jul 18, 2023 · Expires Jul 13, 2043

    granted

  11. US 11701384

    Methods and compositions involving interleukin-6 receptor alpha-binding single chain variable fragments

    The Regents of the University of California · Granted Jul 18, 2023 · Expires Jul 13, 2043

    granted

  12. US 11701307

    Organic-inorganic composite particles, manufacturing method therefor, and cosmetic

    JGC Catalysts and Chemicals Ltd. · Granted Jul 18, 2023 · Expires Jul 13, 2043

    granted

  13. US 11701341

    Use of 3-[5-amino-4-(3-cyanobenzoyl)-pyrazol-1-yl]-n-cyclopropyl-4-methylbenzamide in the treatment of acute exacerbations of chronic obstructive pulmonary disease

    MEREO BIOPHARMA 1 LIMITED · Granted Jul 18, 2023 · Expires Jul 13, 2043

    granted

  14. US 11701431

    Hydrogel prodrug for treatment

    Viking Scientific, Inc. · Granted Jul 18, 2023 · Expires Jul 13, 2043

    granted

  15. US 11701421

    Compositions and methods for stabilizing flaviviruses with improved formulations

    Takeda Vaccines, Inc. · Granted Jul 18, 2023 · Expires Jul 13, 2043

    granted

  16. US 11702473

    Site-specific antibody-drug conjugates

    ADC THERAPEUTICS SA · Granted Jul 18, 2023 · Expires Jul 13, 2043

    granted

  17. US 11702411

    Pyridine, pyrazine, and triazine compounds as allosteric SHP2 inhibitors

    Revolution Medicines, Inc. · Granted Jul 18, 2023 · Expires Jul 13, 2043

    granted

  18. US 11701433

    Complexes for delivery of antigenic peptides

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Jul 18, 2023 · Expires Jul 13, 2043

    granted

  19. US 11702448

    Method of treating melanocortin-4 receptor-associated disorders in heterozygous carriers

    RHYTHM PHARMACEUTICALS, INC. · Granted Jul 18, 2023 · Expires Jul 13, 2043

    granted

  20. US 11702453

    Materials and methods for inhibiting flavivirus infection

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Jul 18, 2023 · Expires Jul 13, 2043

    granted

  21. US 11702630

    In vitro methods of differentiating stem cells into neurons and neurons generated using the same

    The Regents of the University of California · Granted Jul 18, 2023 · Expires Jul 13, 2043

    granted

  22. US 11702656

    Reprogramming of non-neuronal cells into neurons and methods and compositions to treat neurodegenerative diseases and disorders

    The Regents of the University of California · Granted Jul 18, 2023 · Expires Jul 13, 2043

    granted

  23. US 11702477

    Bi-functional chimeric proteins and uses thereof

    Orionis Biosciences, Inc · Granted Jul 18, 2023 · Expires Jul 13, 2043

    granted

  24. US 11702657

    TRNA/pre-miRNA compositions and methods for treating hepatocellular carcinoma

    The Regents of the University of California · Granted Jul 18, 2023 · Expires Jul 13, 2043

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.